Radiation therapy undeniably enhances local control and thus improves overall survival in cancer patients. However, some long-term cancer survivors (less than 10%) develop severe late radio-induced toxicities altering their quality of life. Therefore, there is a need to identify patients who are sensitive to those toxicities and who could benefit from adapted care. In this review, we address all available techniques aiming to detect patients' hyper-radiosensitivity and present the scientific rationales these techniques are based on.
|Original language||English (US)|
|Number of pages||8|
|Journal||Critical Reviews in Oncology/Hematology|
|State||Published - Mar 1 2015|
- Predictive markers
- Radiotherapy outcome
ASJC Scopus subject areas